CCNG2 Antibody - N-terminal region
Artikelnummer:
ASB-AVARP03032_T100
- Bilder (3)
| Artikelname: | CCNG2 Antibody - N-terminal region |
| Artikelnummer: | ASB-AVARP03032_T100 |
| Hersteller Artikelnummer: | AVARP03032_T100 |
| Alternativnummer: | ASB-AVARP03032_T100-25UL,ASB-AVARP03032_T100-100UL |
| Hersteller: | Aviva |
| Wirt: | Rabbit |
| Kategorie: | Proteine/Peptide |
| Applikation: | WB |
| Spezies Reaktivität: | Bovine, Canine, Human, Mouse, Rat |
| Immunogen: | The immunogen is a synthetic peptide directed towards the N terminal region of human CCNG2 |
| The eukaryotic cell cycle is governed by cyclin-dependent protein kinases (CDKs) whose activities are regulated by cyclins and CDK inhibitors. The 8 species of cyclins reported in mammals, cyclins A through H, share a conserved amino acid sequence of about 90 residues called the cyclin box. The amino acid sequence of cyclin G is well conserved among mammals. The nucleotide sequence of cyclin G1 and cyclin G2 are 53% identical. Unlike cyclin G1, cyclin G2 contains a C-terminal PEST protein destabilization motif, suggesting that cyclin G2 expression is tightly regulated through the cell cycle. |
|
|
Host: Rabbit Target Name: CCNG2 Sample Tissue: Human 293T Antibody Dilution: 1.0ug/ml |
|
|
WB Suggested Anti-CCNG2 Antibody Titration: 2.5ug/ml ELISA Titer: 1:312500 Positive Control: Jurkat cell lysate |
|
|
CCNG2 antibody - N-terminal region (AVARP03032_T100) in Human 293T using Western Blot |
Produktgarantie und fachkundiger Support
